HROWL News and Press, Harrow Health Inc. 8.625% senior notes due 2026 From 05/11/23

2023-05-11 21:43:09 ET Harrow Health, Inc. (HROW) Q1 2023 Earnings Conference Call May 11, 2023, 4:45 PM ET Company Participants Jamie Webb - Director, Communications and IR Mark Baum - Chief Executive Officer Andrew Boll - Chief Financial Officer Conferenc...

2023-03-23 20:58:06 ET Harrow Health, Inc. (HROW) Q4 2022 Earnings Conference Call March 23, 2023, 4:45 PM ET Company Participants Jamie Webb - Director, Communications and IR Mark Baum - Chief Executive Officer Andrew Boll - Chief Financial Officer Confere...

Summary Harrow is a slow and steady seller of various ophthalmic products. In the last few months, it has gone up considerably. I expect more from the company, although I am still trying to figure out their strengths and weaknesses. I covered Harrow Health ( HROW )...

Summary SRK Capital, LLC provides investment management services to an investment partnership, SRK Fund I, LP. SRK Fund I, LP appreciated 35.31% during 2022. 2023 stock market returns will be determined by the direction of earnings. Dear Partners, SRK Fund I, LP apprec...

Summary As December 2022 comes to a close, we observe six new preferred stock / exchange-traded-debt (ETD) offerings during the month, offering annual yields ranging from 6.75% to 11.875%. Here is a comparison against the highest quality preferred stocks in our coverage universe, as ran...

Sienna Harrow Health, Inc. (HROW) Q3 2022 Earnings Conference Call November 14, 2022 4:45 PM ET Company Participants Jamie Webb – Director-Communications and Investor Relations Mark L. Baum – Chief Executive Officer Andrew Boll – Chief Financ...

In 2021 Harrow Health began to expand into branded pharmaceutical products (BPP) by acquiring the rights to several new products. The expansion into BPP has led to increased costs. With HROW stock down roughly 45% from its highs, I believe the market is missing the forest for the ...

SRK Capital, LLC provides investment management services to an investment partnership, SRK Fund I, LP. SRK Fund I, LP declined -17.57% during the first half of 2022. Permanent capital loss is not equal to stock price quotational loss (which I pay little attention to). The pres...

Harrow Health, Inc. (HROW) Q2 2022 Earnings Conference Call August 9, 2022 4:45 P.M. ET Company Participants Jamie Webb - Director of Communications and Investor Relations Mark Baum - Chief Executive Officer and Chairman of the Board Andrew Boll - Chief Financial...

Harrow Health’s (HROW) Q1 2022 Earnings Conference Call May 05, 2022 04:45 PM ET Company Participants Jamie Webb - Director of Communications and Investor Relations Mark Baum - Chief Executive Officer and Chairman of the Board Andrew Boll - Chief Financial Officer Conference Call Parti...